 Dr. Manar Al Moneef,
Director General Saudi Arabia Government Investment Authority Dr. Manar Al-Moneef is a highly accomplished enterprising visionary that combines outstanding life science and health care business promotion talents with high caliber general management qualifications; Result oriented, decisive leader, with proven success record in establishing new business in Saudi Arabia, identifying growth opportunities, and initiating strong business alliances. Develop international partnerships to drive bottom-line profits. Thrive in dynamically changing environments requiring focused decision making. Acknowledged for well-defined understanding of the business technology interface to identify and align clients emerging technology needs with products and services. A successful and diverse background spanning medical, technical and academia.
Dr. Manar Al-Moneef is the Director General of Health Care & Life Sciences at the Saudi Arabian General Investment Authority (SAGIA), the government agency responsible for promoting investments in the Kingdom and improving its investment environment. At SAGIA, Dr. Al-Moneef is responsible for providing strategic and technical consulting in all health care and life science business development; lead all health care and life science strategic-driven revenue models. Lead all health care and life Sciences investments which include (heath care strategies, health care investments, pharmaceutical, bio-pharmaceutical, medical devices, agrochemical, agriculture, aqua-agriculture, biomass and marina life science, fine chemical production, industrial enzymes production, biotech pollution and biotech application for water treatment, renewable and alternative energy and all environmental initiatives). She also developed the new health care and life science strategy for the economic cities which include developing new licensing regulation, developing an e-based monitoring and evaluation system, developing the strategies for creating a pharmaceutical cluster, agrochemical cluster, a fine chemical cluster and finally a solar cluster. Create supportive regulatory framework benchmarked to international best practice and the development of unique value propositions for each segment.
Benchmarks and milestones’
• Distinguished for developing a qualified pipeline of life sciences and health care business opportunities of $34 billion covering all segments of life science and health care.
• Gained distinction as a superior health care and life sciences investment promotion business performer, accomplishing $ 6.5 billion sales to budget from a zero base in just 12 months.
Prior to joining SAGIA, Dr. Al-Moneef was the Director of Molecular Pathology & Genetics at King Abdulaziz Medical City, National Guard Hospital in Riyadh, Saudi Arabia. During that time she evaluated different research projects which involved the development of a novel assay. She was also appointed as an Assistant Professor at King Saud University for Medical Studies.
Dr. Al-Moneef has a Doctoral Degree in Molecular OncologAppearing: Conference Day One: Tuesday 30th November 2010 12pm Developments and current opportunities in Saudi Arabia’s healthcare
- Overview of SAGIA and competitiveness
- Healthcare development, challenges and opportunities
- Economic city healthcare vision
Dr. Manar Al Moneef, Director General,
Saudi Arabia Government Investment Authority 2.30pm Panel Discussion: Innovative investment models for building a sustainable infrastructure
- How is the current economic climate affecting investor appetite and availability of financing?
- How governments and operators create a compelling proposition for investors
- Due diligence and risk management strategies used before embarking on investments
- When and where are the next investment opportunities?
Dr. Manar Al Moneef, Director General,
Saudi Arabia Government Investment Authority Mr. James Gordan Pincock, Managing Director,
ICME CEO and Member of the Board,
Ithmaar Development Company |
|
media partners
Intelligence Partner
|
|
|
|
©Terrapinn Holdings Ltd. MMX